Michael Scully
7Patents
4h-index
20Co-inventors
57Inventor score
Filing activity: Mar 30, 1998 → May 19, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9102737B2 | Human anti-CD27 antibodies, methods and uses | Chemistry; Metallurgy | 26 | Active |
| US6127340A | Serine protease inhibitors | Human Necessities | 8 | Expired |
| US6451976B1 | Bi-or multifunctional molecules based on a dendroaspin scaffold | Chemistry; Metallurgy | 8 | Expired |
| US9683046B2 | Nucleic acid molecules encoding anti-CD27 antibodies | Chemistry; Metallurgy | 7 | Active |
| US10301392B2 | Methods of inhibiting T-cell mediated B-cell antibody production using anti-CD27 antibodies | Chemistry; Metallurgy | 2 | Active |
| US10689453B2 | Methods of inhibiting naive T-cell proliferation using anti-CD27 antibodies | Chemistry; Metallurgy | 0 | Active |
| US11732050B2 | Neutralizing human anti-CD27 antibodies | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.